2006•Journal of Clinical CardiologyRequires access

Effects of rosiglitazone on the serum lipids and total antioxidative abilities in atherosclerotic rabbits

Zhaohui Wang

Open publisher page 0 citations

Abstract

Objective: To study the effects of rosiglitazone on the atherosclerotic plaque in rabbits. Method: Twenty-four male New Zealand white rabbits weighing 1. 8 to 2. 2 kg were randomly divided into 3 groups: control group (normal rabbits diet), cholesterol group (cholesterol diet), Rosiglitazone group (cholesterol diet supplemented with rosiglitazone since 10th week). Rabbits in cholesterol group and rosiglitazone group were sequentially fed 1% cholesterol-containing diet for 16 weeks. At the end of the experiment,blood glucose,serum lipids levels, ratio of plaque area to aorta area were measured and total antioxidative abilities were determinated with chroma-tometry. Result: Hypercholesterolemia was successfully induced. After rosiglitazone intervention, level of serum TC, LDL-C, and ratio of plaque area to aorta area had significant difference between cholesterol group and rosiglitazone group ( P 0. 05). Total antioxidative abilities were stronger in rosiglitazone group than those in cholesterol group. Conclusion:Our study showed rosiglitazone had effects on atherosclerotic plaque regression by decreasing levels of TC and LDL and increasing total antioxidative abilities of blood vessel.

About this research paper

What this paper is about

Objective: To study the effects of rosiglitazone on the atherosclerotic plaque in rabbits. Method: Twenty-four male New Zealand white rabbits weighing 1. 8 to 2. 2 kg were randomly divided into 3 groups: control group (normal rabbits diet), cholesterol group (cholesterol diet), Rosiglitazone group (cholesterol diet supplemented with rosiglitazone since 10th week). Rabbits in cholesterol group and rosiglitazone group were sequentially fed 1% cholesterol-containing diet for 16 weeks. At the end of the experiment,blood glucose,serum lipids levels, ratio of plaque area to aorta area were measured and total antioxidative abilities were determinated with chroma-tometry. Result: Hypercholesterolemia was successfully induced. After rosiglitazone intervention, level of serum TC, LDL-C, and ratio of plaque area to aorta area had significant difference between cholesterol group and rosiglitazone group ( P 0. 05). Total antioxidative abilities were stronger in rosiglitazone group than those in cholesterol group. Conclusion:Our study showed rosiglitazone had effects on atherosclerotic plaque regression by decreasing levels of TC and LDL and increasing total antioxidative abilities of blood vessel.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To study the effects of rosiglitazone on the atherosclerotic plaque in rabbits. Method: Twenty-four male New Zealand white rabbits weighing 1. 8 to 2. 2 kg were randomly divided into 3 groups: control group (normal rabbits diet), cholesterol group (cholesterol diet), Rosiglitazone group (cholesterol diet supplemented with rosiglitazone since 10th week). Rabbits in cholesterol group and rosiglitazone group were sequentially fed 1% cholesterol-containing diet for 16 weeks. At the end of the experiment,blood glucose,serum lipids levels, ratio of plaque area to aorta area were measured and total antioxidative abilities were determinated with chroma-tometry. Result: Hypercholesterolemia was successfully induced. After rosiglitazone intervention, level of serum TC, LDL-C, and ratio of plaque area to aorta area had significant difference between cholesterol group and rosiglitazone group ( P 0. 05). Total antioxidative abilities were stronger in rosiglitazone group than those in cholesterol group. Conclusion:Our study showed rosiglitazone had effects on atherosclerotic plaque regression by decreasing levels of TC and LDL and increasing total antioxidative abilities of blood vessel.

Key concepts: Rosiglitazone, Medicine, Internal medicine, Cholesterol, Endocrinology, Blood lipids, Aorta, Total cholesterol

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of rosiglitazone on the serum lipids and total antioxidative abilities in atherosclerotic rabbits — Research Paper | ScholarLens